The localization in infected and transformed cells of the two major adenovirus type 2 Ela proteins, of 289 and 243 amino acid residues, was studied with antisera raised against synthetic peptides or a TrpE-Ela fusion protein. Production of antisera. The peptides acetyl-Tyr-Gly-LysArg-Pro-Arg-Pro (peptide 9) and acetyl-Lys-His-Try-HisArg-Arg-Asn-Thr-Gly-Asp-Pro-Asp-Ile-Met-Cys-Tyr (peptide 23) were synthesized by the Merrifield technique with a Vega peptide synthesizer as previously described (24). Peptide 9 consists of the C-terminal five residues of the Ela 289R and 243R proteins with the addition of two residues at the N terminus to facilitate conjugation to carrier protein and to substrates for affinity chromatographic purification of antipeptide antiserum. This is the same sequence used by Yee et al. (43) per mol of bovine serum albumin and from 1.3 to 3.4 mol of peptide 23 per mol of ovalbumin. Rabbits were immunized with peptide-carrier conjugates, and antibodies were purified by affinity chromatography as previously described (2).
respectively, only the 289-residue or only the 243-residue Ela protein. However, the 289-residue protein was more tightly associated with the nucleus than was the 243-residue protein, as determined by the stability of nuclear fluorescence to different fixation procedures and by the use of radioimmunoprecipitation and Western blot analysis to analyze fractions extracted from the nucleus by detergent and other treatments. The latter experiments revealed that only the 289-residue protein, and only a fraction of that protein present in the nucleus, is associated with the nuclear matrix, both in infected HeLa cells and in the transformed human cell line 293.
Transcription region Ela of the human adenoviruses (Ad's) encodes two closely related proteins of 289 and 243 amino acid residues (289R and 243R proteins), differing only by the internal 46 residues unique to the larger protein (29) . These two proteins have been implicated to different degrees in the various functions attributed to region Ela. Both Ela gene products play roles in the transformation of rodent cells (16, 19, 26, 41) . The larger protein (289R protein) is necessary (4, 9, 30) and sufficient (27) for the enhancement of early viral gene expression during infection, but the smaller protein (243R protein) enhances viral DNA replication in growth-arrested cells (34) . Both the 289R and the 243R proteins apparently repress enhancer-mediated transcription in transient expression assays (5, 38) , but only the 243R protein specifically represses transcription from the adenovirus E2 late promoter (15) .
Very little is known of any differences between the two proteins in biochemistry or cellular localization that might reflect the above differences in function. Both Ela proteins are present in both nuclear and cytoplasmic fractions prepared from infected cells (18, 31) , although immunofluorescence studies show the majority of the Ela proteins to be nuclear (11, 43) . Using an antiserum that would recognize only the 289R protein, Feldman and Nevins (11) reported that the majority of the 289R protein in the nucleus is associated with the nuclear matrix fraction and suggested that this association could be connected with the role of the 289R protein as a transcriptional regulatory protein. Moreover, the myc protein, the product of an oncogene similar in several biological aspects to Ela, has also been reported to be nuclear matrix associated (8) . We used several complementary methods to further investigate the intracellular localization of both major Ela proteins and found that both are nuclear proteins and that a minority of the 289R protein is associated with the nuclear matrix. In contrast, the 243R protein and the majority of the 289R protein are extractable from the nucleus by treatment with detergents.
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MATERIALS AND METHODS
Production of cells and viruses. Monolayers of HeLa and 293 cells were maintained in Dulbecco modified Eagle medium supplemented with 5% fetal bovine serum. Ad serotype 2 (Ad2) stocks were propagated on HeLa cells, and Ad2/Ad5 mutants pm975 and d11500 (kindly provided by A. Berk) were propagated on either HeLa or 293 cells.
Production of antisera. The peptides acetyl-Tyr-Gly-LysArg-Pro-Arg-Pro (peptide 9) and acetyl-Lys-His-Try-HisArg-Arg-Asn-Thr-Gly-Asp-Pro-Asp-Ile-Met-Cys-Tyr (peptide 23) were synthesized by the Merrifield technique with a Vega peptide synthesizer as previously described (24) . Peptide 9 consists of the C-terminal five residues of the Ela 289R and 243R proteins with the addition of two residues at the N terminus to facilitate conjugation to carrier protein and to substrates for affinity chromatographic purification of antipeptide antiserum. This is the same sequence used by Yee et al. (43) (2) .
A TrpE-Ela conjugate DNA clone (supplied by A. Berk) was used to raise polyclonal antiserum as described previously (35) .
Immunofluorescence. One day before infection, HeLa cells were plated onto cover slips at a density of 106 cells per 6-cm dish. Cells were washed once with Dulbecco modified Eagle medium without serum and infected with 1 ml of virus containing 108 PFU. After adsorption for 1 h, the virus inoculum was removed by aspiration, the cells were washed twice with medium, and 5 ml of Dulbecco modified Eagle medium with 5% fetal bovine serum was added back. Cover slips at 12 h postinfection (p.i.) were washed once with Dulbecco modified Eagle medium without serum and fixed by one of two methods. Formalin fixation was accomplished by incubation of cover slips in 5% Formalin in PBS at room temperature for 20 min, followed by three 5-min rinses in PBS. Cells so fixed were permeabilized by incubation in 1% Nonidet P-40 in PBS for 20 min at room temperature immediately before reaction with antibodies. For acetone fixation, cells on cover slips were immersed in cold (-5°C) acetone for 1.5 min, air dried, and stored at -20°C until use. Cells fixed in acetone were rehydrated in PBS just before reaction with antibodies.
Cover slips were overlaid with a 10-,ug/ml solution of affinity-purified antipeptide serum, incubated for 45 min at 37°C, washed in PBS, and then overlaid with a 1:5 dilution of affinity-purified rhodamine-conjugated goat anti-rabbit immunoglobulin G (kindly supplied by L. Rohrschneider). After a second 45-min incubation, cover slips were washed in PBS, rinsed in distilled water, and mounted in Gelvatol (Monsanto). In control experiments, antipeptide serum at 10 ,ug/ml was incubated at 4TC for 30 min with an excess of the cognate peptide before use on infected cells.
Stained cover slips were viewed with a Zeiss fluorescence microscope and photographed through a 63 x oil immersion objective on Tri-X-pan film (Eastman Kodak Co., Rochester, N.Y.), which was developed at ASA 1600. All exposure times were 1.5 to 2 min.
Nuclear matrix preparation. HeLa cell monolayers were infected with Ad2 and labeled with [35Sjmethionine for 2 h before nuclear matrix preparation, which was done essentially as described by Feldman and Nevins (11) (method 1). The final pellet (the nuclear matrix) was suspended in 1% Sarkosyl and heated in a boiling water bath for 5 min or sonicated four times for 15 s each time at 50 W in 0.2 M Tris hydrochloride (pH 7.4)-0.05 M NaCl, 0.5% Nonidet P-40, 0.5% sodium deoxycholate, and 0.5% sodium dodecyl sulfate (SDS) (3-D buffer). The resulting fractions were analyzed by immunoprecipitation as described below. Alternatively, the nuclear matrix fraction was prepared essentially as described by Staufenbiel and Deppert (36) (method 2). Monolayers were infected and labeled as in method 1. All washes and extractions were performed in situ. The residue remaining adhering to the plate was washed two times with 10 mM MES (morpholineethanesulfonic acid) (pH 6.2)-10 mM NaCl-1.5 mM MgCl2-5 mM dithiothreitol-1 mM EGTA-1% aprotinin-10% glycerol and then scraped into 3-D buffer and sonicated.
Radioimmunoprecipitation. HeLa cell monolayers were infected with adenovirus and labeled with [35S]methionine as described by Anderson et al. (1) . For the cell extracts used in Fig. 1 , the metabolic inhibitors cycloheximide and cytosine arabinoside were used to increase the amount of Ela proteins synthesized, as described by Harter and Lewis (18) and Gaynor et al. (13) . In all other experiments, cells were labeled as indicated in the figure legends without prior treatment with inhibitors. Extracts of cells were analyzed by immunoprecipitation as previously described (reference 2, as modified in reference 25). (20 mM Tris hydrochloride [pH 7.5], 0.5 M NaCl, 0.5% Tween 20), 2 M NaCl, 2 M urea, and then TTBS, blots were probed with S x 105 dpm of 1251-labeled protein A (New England Nuclear Corp., Boston, Mass.). The labeled blot was then washed as above and exposed to X-ray film at -70°C with an intensifying screen (Du Pont Co., Wilmington, Del.).
RESULTS
Specificity of peptide antisera for Ela proteins. Both the Ela 289R and 243R proteins can be resolved electrophoretically into multiple species when synthesized both in vivo and in vitro (7, 9, 17, 18, 32) . When analyzed by onedimensional SDS-PAGE, the 289R protein appeared as a 58-and a 48-kilodalton species, and the 243R protein appeared as a 54-and a 42-kilodalton species. The antiserum to peptide 9 (which should react with both the 289R and the 243R proteins) precipitated all four species, while the antiserum to peptide 23 (which should react with only the 289R protein) precipitated only the 58-and 48-kilodalton species ( Fig. 1) , confirming the previously reported correlation between the four electrophoretic species and the two Ela protein sequences. None of these four species were precipitated with extracts prepared from mock-infected cells or with preimmune antisera or immune antisera blocked by pretreatment with excess immunogenic peptide. In lane f two additional species of less than 42-kilodaltons can also be seen, the larger of which is related to the 289R protein (lane h). These minor species were not considered in the following experiments because they were not consistently detected in extracts containing less Ela protein.
Localization of Ela proteins to the nucleus by immunofluorescence. Immunofluorescence on Formalin-fixed, detergent-permeabilized HeLa cells at 12 h p.i. with antiserum to peptide 9 demonstrated that Ela proteins localize to the nucleus, giving a diffuse fluorescence excluded from the nucleoli ( Fig. 2A) . The specificity of anti-peptide 9 fluorescence is shown by the absence of fluorescence in mockinfected cells (Fig. 2D ) and the blocking of nuclear fluorescence by preincubation of antiserum with the cognate peptide (Fig. 2E) . The small amount of diffuse cytoplasmic fluorescence seen in the latter case is presumed due to nonspecific interactions of the peptide with cytoplasmic structures. Nuclear localization of Ela proteins was seen not only with wild-type Ad2, but also with Ad2/AdS mutants pm975 (27) (Fig. 2B ) and dll500 (26) (Fig. 2C ), which produce, respectively, only the 289R and 243R Ela products. The same pattern of fluorescence was observed in Formalin-fixed infected cells with antisera to peptide 23 or to the TrpE-Ela fusion protein (data not shown).
Considerable cell-to-cell variation in the intensity of Elaspecific immunofluorescence was consistently observed with all viruses used even though fluorescence was detectable in 95 to 100% of the cells in each experiment, as expected after infection at high multiplicity. This variable intensity could arise from some asynchrony in the very early stages of infection that might lead to asynchronous expression of the Ela gene. However, we saw the same cell-to-cell variation in intensity of fluorescence in the stably transformed cell line 293 (14) (data not shown). Alternatively, Ela gene expression might be regulated according to the physiological state of the cell in which it is expressed, e.g., its stage in the cell cycle. Consistent with this explanation is the report by Kao et al. (20) , that Ela mRNA levels are regulated posttranscriptionally with respect to the cell cycle.
If virally infected cells are fixed in cold acetone rather than Formalin before reaction with Ela-specific antibodies, a somewhat different picture emerges. Ad2 (Fig. 2F )-and pm975 ( Fig. 2G )-infected cells retained their nuclear fluorescence when reacted with antibodies to peptide 9. d11500-infected cells, however, were generally negative for Elaspecific fluorescence with antiserum to peptide 9 ( Fig. 2H) , although d11500-infected cells showed staining of equivalent brightness to that of Ad2-or pm975-infected cells when fixed with Formalin (Fig. 2C) . The smaller Ela protein thus appears to be dispersed from infected cells or to lose its antigenicity. With this antiserum we were unable to determine whether the smaller protein is actually lost from the cell or is deprived of immunoreactivity by acetone fixation through conformational or other change unique to the 243R protein.
Association of Ela 289R protein with nuclear matrix. Subcellular fractions prepared by method 1 were analyzed for the presence of Ela proteins by radioimmunoprecipitation with antiserum to peptide 9. Both the Ela proteins were most abundant in the material extracted by treatment with Nonidet P-40 (the cytoplasmic fraction plus material extracted from the nucleus by detergent) (Fig. 3, lane a, and Fig. 4, lane b) . A fraction of the Ela protein present in the cell, however, remained in the nucleus. This material consisted largely of the 289R protein (Fig. 3, lanes j and 1, and  Fig. 4, lane d) . In some experiments additional Ela proteins were washed from the nucleus with Triton X-100 (Fig. 3, lane c). This wash contained both Ela proteins; however, the level of the 243R protein was reduced relative to that of the 289R protein. Only the 289R protein was left in the nucleus afer the detergent treatments (Nonidet P-40 extraction plus Triton X-100 wash) since the 243R protein could not be recovered in any of the subsequent fractions (Fig. 3,  lanes d to m) . In addition, the 289R protein that remained with the nucleus was associated with the nuclear matrix fraction since, of the subsequent fractions, only the nuclear matrix contained detectable amounts of the 289R protein (Fig. 3, lanes j and 1) . This nuclear matrix association of the 289R protein, and not the 243R protein, was also seen when samples were analyzed by Western blotting (Fig. 5, lane d) .
The significance of nuclear matrix localization has been questioned by reports that some experimental manipulations can irreversibly precipitate specific proteins, leading to artifactual association with the matrix. For example, Spindler et al. (35) report that Ela proteins can be extracted from the nucleus at intermediate salt concentration, implying that the apparent association with the nuclear matrix fraction is due to insolubility of Ela protein at high salt concentrations. Therefore, nuclear matrix fractions were prepared substituting a 0.25 M ammonium sulfate wash for the 2 M NaCl step (6) . This procedure gave results identical to those obtained with the 2 M NaCl wash of Feldman and Nevins (11) (Fig. 3 , compare lane 1 with lane j). It has also been reported (10) that the nuclear matrix association of some oncogenes (v-myc, c-myc, and v-myb) is due to irreversible insolubilization produced by incubation at temperatures above 35°C during the fractionation procedure. To (9) . Samples were analyzed on 15% (lanes a to e) or 10% (lanes f to i) polyacrylamide gels and exposed for fluorography for 3 days (lanes a to e) or 12 days (lanes f to i). K, Kilodaltons. using a maximum temperature of 27°C instead of 37TC. Preparation at 27°C did not alter the association of the 289R Ela protein with the nuclear matrix fraction (Fig. 4, lane i) .
To determine how these two classes of 289R protein (loosely nuclear associated and nuclear matrix associated) varied in abundance as a function of the overall levels of Ela protein in the cell, we measured the nuclear matrix localization in cells infected at different multiplicities. The total amount of Ela protein in the cytoplasmic fraction increased with increased multiplicity of infection (MOI) from 5 to 150 PFU per cell (Fig. 4, lanes e, f, and g ), but the amount recovered in the nuclear matrix was relatively independent of MOI (Fig. 4, lanes h, j, and k) , so that at low MOI a relatively larger fraction of the 289R protein was nuclear matrix localized. However, even at 5 PFU per cell, the majority of the 289R protein in the cell was extracted from the nucleus by detergent treatment. Densitometric analysis of the fluorograms used for Fig. 4 indicated that synthesized by cell-free translation that could be recovered by immunoprecipitation after mixing with unlabeled cell fractions (data not shown).
If nuclear matrix localization of the 289R protein is a fundamental property important for the function of this protein, it should be in the nuclear matrix of Ad-transformed as well as infected cells. Accordingly, the nuclear matrix fraction was isolated from 293 cells, a line of human embryonic kidney cells transformed by Ad5 DNA which constitutively express the Ad5 Ela and Elb regions (14) . As in infected HeLa cells, the 289R protein was found in the nuclear matrix fraction and the 243R protein was absent (Fig. 6, lane n) . The characteristic four bands of the Ela proteins precipitated from 293 cells were altered in that 293 cells contained only the more slowly migrating forms of the 289R and 243R proteins. Further, Ad5 Ela proteins migrate more slowly (9) than do the Ad2 Ela proteins used as markers in Fig. 6 (Fig. 6, lane d) , while cells infected with mutant d11500 did not contain any detectable Ela protein in the nuclear matrix fraction (Fig. 6, lane i) . Using Western blot analysis, similar results were obtained (Fig. 5) . Small amounts of the 243R protein, however, were seen in the nuclear matrix in the Western blot prepared from cells infected with the d11500 mutant (Fig. 5, lane f) . This is in contrast to the results seen by radioimmunoprecipitation analysis (Fig. 6 , lane i) and the result seen on fractionation of cells infected with wild-type Ad in which no 243R protein was seen in the nuclear matrix (Fig. 5, lane d) . However, the fraction of Ela protein in the nuclear matrix of d11500- To check the generality of our results, we also prepared nuclear matrices by a very different method. Results with method 2 (Fig. 7) differed from those obtained with method 1 in several ways. First, much less Ela protein was found in the cytoplasmic fraction, and a correspondingly greater fraction was obtained in the nuclear matrix. Second, the nuclear matrix fraction contained the 243R protein as well as the 289R protein, the amounts varying in different experiments from very low to significant levels. Third, a large fraction of the Ela protein in this preparation remained in the Empigen BB-insoluble fraction that adhered to the tissue culture dish after solubilization of the nuclear matrix (Fig. 7 , lane e), and this fraction contained only the 289R protein.
As an additional comparison of the two fractionation methods, samples of fractions prepared by each method were analyed by SDS-PAGE and, in parallel experiments, either stained to visualize total protein content or exposed for fluorography to detect pulse-labeled proteins (Fig. 8 For the experiments in lanes e to h, j, and k, one plate was infected at 5 PFU per cell (lanes e and h), one plate was infected at 50 PFU per cell (lanes f and j), and one plate was infected at 150 PFU per cell (lanes g and k) . An amount of cytosol from each plate equivalent to one-half plate of cells was analyzed by immunoprecipitation (lanes e to g), and the nuclear matrix fraction (method 1) from each entire plate was analyzed (lanes h, j, and k). All procedures were at 4°C or on ice except for the DNase digestions, which were done at 37°C. In one experiment (lane i), the nuclear matrix fraction was prepared (from cells that had been infected at 50 PFU per cell) by DNase digestion at 27°C instead of 37°C. Ela marker proteins synthesized by translation in vitro are shown in lanes a and 1. Electrophoresis was on an SDS-10% polyacrylamide gel which was dried and exposed for fluorography for 13 h (lanes a to g and 1) or for 4 days (lanes h to k).
Both analyses showed significant differences in the protein composition of the nuclear matrix fractions prepared by the two methods.
DISCUSSION
The immunofluorescence experiments with Formalin fixation before permeabilization reported here confirm the nuclear localization of the Ela proteins in Ad2-infected HeLa cells. In addition, we demonstrated that during viral infection the nuclear localization of each of the Ela proteins (243R and 289R) is independent of the other since this localization is observed in cells infected with mutants that synthesize only one or the other of the two proteins as well as in wild-type infection in which both proteins are present. This localization of the Ela proteins agrees well with the results of Krippl et al. (22) amount of cytoplasmic fluorescence in addition to nuclear fluorescence. A similarly fragile nuclear association has been noted for the estrogen receptor (21, 40) .
The loss of most immunofluorescence from cells that contain only the 243R protein under conditions (acetone fixation) in which cells that contain only the 289R protein retain fluorescence strongly suggests that the two Ela proteins interact differently with nuclear components. Such a difference is further supported by fractionation of the nucleus by treatment with detergents, salt, and DNase. The 243R protein is completely extracted from the nucleus, while a portion of the 289R protein is retained in the residual nuclear matrix. Feldman and Nevins (11) had previously demonstrated the 289R protein to be present in the nuclear matrix; however, the antiserum they used recognized only the 289R protein and therefore would not have detected the 243R protein had it been present. The absence of the 243R protein in the nuclear matrix is evident by Western blot assay as well as by immunoprecipitation and so cannot be attributed to incomplete or differential solubilization of the Ela proteins in the nuclear matrix by the buffer used for immunoprecipitation. The nuclear matrix localization of the 289R protein is not dependent upon the 243R protein since it is also seen in mutant-infected cells lacking the 243R protein.
It is also independent of other Ad proteins, possibly excepting the Elb proteins, since the 289R protein is associated with the nuclear matrix in 293 cells which constitutively express the Ad Ela and Elb regions and no other Ad regions.
Although concerns have been expressed that nuclear matrix localizations of Ela or other oncogene proteins might be artifacts owing to insolubilization in the presence of high salt (35) If the capacity of the nuclear matrix to bind Ela protein is limited, the absence of the 243R protein from the matrix could result from competition by the 289R protein rather than from lack of competence to localize in the matrix. This possibility is eliminated by our finding that little or no association of the 243R protein with the matrix occurs even in d11500-infected HeLa cells, which contain no 289R protein.
The term nuclear matrix refers to a physical structure which remains poorly defined and controversial, its composition varying with the procedure used in its isolation. As an illustration of this issue we included results of experiments after a second extraction procedure. Using method 2 we found both the 243R and 289R Ela proteins in the nuclear matrix. This inconsistency with our other data is not surprising given methodological differences which include pH and salt conditions of the initial extractions and the buffering system used. However, further extraction of the nuclear matrix of method 2 with the detergent Empigen BB removed the 243R protein, leaving the 289R protein associated with the insoluble residue. Analysis of the protein content of nuclear matrices prepared by these two methods demonstrates that they do differ in ways other than Ela content and that the Empigen-insoluble fraction from method 2, rather than the nuclear matrix fraction from method 2, more closely resembles the nuclear matrix fraction from method 1. Regardless of the details of the differences and of what one calls a nuclear matrix, it is clear that the two procedures each define a fraction of the nucleus which contains only one of the two Ela proteins, the 289R protein.
The principal question raised by these results is whether or not the fraction of the 289R protein that is localized in the nuclear matrix is responsible for the unique function a to e are fractions prepared by method 1: a, cytosol (Nonidet P-40 extract); b, Triton X-100 wash; c, DNase I wash; d, 2 M NaCl wash; e, nuclear matrix. Lanes g to k are fractions prepared by method 2: g, cytosol; h, DNase I wash; i, 2 M NaCl wash; j, Empigen BB-solubilized fraction (nuclear matrix); k, Empigen BB-insoluble fraction. Lane 
